An eight-year-old boy presented with left eye pain, photophobia, proptosis, third nerve paresis and decreased visual acuity. Magnetic resonance imaging revealed a nonenhancing mass filling the cavernous sinus. Using an extradural fronto-orbitozygomatic approach, the cavernous sinus was approached laterally, and a teratoma was removed from within the cavernous sinus. This is the first case of a truly intracavernous teratoma in a child and the fourth case of a teratoma reported in the cavernous sinus region overall. This report outlines the diagnosis and treatment of this unusual cavernous sinus tumor.

1.
Parkinson D: A surgical approach to the cavernous portion of the carotid artery: Anatomical studies and case report. J Neurosurg 1965;23:473–483.
2.
Inoue T, et al: Surgical approaches to the cavernous sinus: A microsurgical study. Neurosurgery 1990;26:903–932.
3.
Sekhar LN, Janecka IP: Surgery of Cranial Base Tumors. New York, Raven Press, 1993.
4.
Zulch KJ: Brain Tumors: Their Biology and Pathology, ed 2. New York, Springer-Verlag, 1965.
5.
Ingraham FD, Bailey OT: Cystic teratomas and teratoid tumors of the central nervous system in infancy and childhood. J Neurosurg 1946;3:511–532.
6.
Pikus HJ, Holmes B, Harbaugh RE: Teratoma of the cavernous sinus: Case report. Neurosurgery 1995;36:1020–1023.
7.
Hakuba A, et al: Surgical Approaches to the cavernous sinus: Report of 19 cases. Neurol Med Chir (Tokyo) 1982;22:295–308.
8.
Ashley DJB: Origin of teratomas. Cancer 1973;32:390–394.
9.
Carmel PW: Brain tumors of disordered embryogenesis; in Youmans JR (ed): Neurological Surgery. Philadelphia, Saunders Co, 1996, pp 2777–2778.
10.
Jennings MT, Gelman R, Hochberg F: Intracranial germ cell tumors: Natural history and pathogenesis. J Neurosurg 1985;63:155–167.
11.
Russell DS, Rubinstein LJ: Pathology of Tumors of the Nervous System, ed 5. Baltimore, Williams & Wilkins, 1989, pp 681–687.
12.
Tekeuchi A, Mori K, Moritake K, et al: Teratomas in the suprasellar region: Report of five cases. Surg Neurol 1975;3:247–255.
13.
El-Kalliny M, van Loveren H, Keller JT, et al: Tumors of the lateral wall of the cavernous sinus. J Neurosurg 1992;77:508–514.
14.
Matsutani M, et al: Primary intracranial germ cell tumors: A clinical analysis of 153 histologically verified cases. J Neurosurg 1997;86:446–455.
15.
Ng HK, Poon WS, Chan YL: Basal ganglia teratomas: Report of three cases. Aust N Z Surg 1992;62:436–440.
16.
Fujimaki T, et al: CT and MRI features of intracranial germ cell tumors. J Neurooncol 1994;19:217–226.
17.
Sekhar LN, Burgess J, Akin O: Anatomical study of the cavernous sinus emphasizing operative approaches and related vascular and neural reconstruction. Neurosurgery 1987;21:806–816.
18.
Duma CM, et al: Stereotactic radiosurgery of cavernous sinus meningiomas as an addition or alternative to microsurgery. Neurosurgery 1993;32:699–705.
19.
Ono N, et al: Factors affecting functional prognosis in survivors of primary central nervous system germinal tumors. Surg Neurol 1994;41:9–15.
20.
Sekhar LN, Moller AR: Operative management of tumors involving the cavernous sinus. J Neurosurgery 1986;64:879–889.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.